These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 21413423)

  • 21. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
    Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control.
    Carmeli Y; Akova M; Cornaglia G; Daikos GL; Garau J; Harbarth S; Rossolini GM; Souli M; Giamarellou H
    Clin Microbiol Infect; 2010 Feb; 16(2):102-11. PubMed ID: 20085604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Imipenem resistance in Gram-negative rods and its consumption between 1999 and 2005].
    Gospodarek E; Gierlotka K; Deptuła A; Michalska A
    Med Dosw Mikrobiol; 2007; 59(3):231-40. PubMed ID: 18078118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will new antimicrobials overcome resistance among Gram-negatives?
    Bassetti M; Ginocchio F; Mikulska M; Taramasso L; Giacobbe DR
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):909-22. PubMed ID: 21973303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors and etiology of neonatal sepsis in Tikur Anbessa University Hospital, Ethiopia.
    Shitaye D; Asrat D; Woldeamanuel Y; Worku B
    Ethiop Med J; 2010 Jan; 48(1):11-21. PubMed ID: 20607993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Extended spectrum beta-lactamse (ESBL)-induced antibiotics resistance in gram-negative agents: what should be watched in intensive care medicine?].
    Kola A; Gastmeier P
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Sep; 38(9):573-6. PubMed ID: 12975735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiresistant Gram-negative infections: a global perspective.
    Ho J; Tambyah PA; Paterson DL
    Curr Opin Infect Dis; 2010 Dec; 23(6):546-53. PubMed ID: 20802331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The burden of multiresistant bacteria in German intensive care units.
    Meyer E; Gastmeier P; Schwab F
    J Antimicrob Chemother; 2008 Dec; 62(6):1474-6. PubMed ID: 18794158
    [No Abstract]   [Full Text] [Related]  

  • 32. Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.
    Furtado GH; Perdiz LB; Santana IL; Camargo MM; Parreira FC; Angelieri DB; Medeiros EA
    Am J Infect Control; 2008 Nov; 36(9):661-4. PubMed ID: 18834728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of carbapenems in the treatment of serious infections.
    Baughman RP
    J Intensive Care Med; 2009; 24(4):230-41. PubMed ID: 19617229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia.
    Kader AA; Kumar AK
    Saudi Med J; 2004 May; 25(5):570-4. PubMed ID: 15138522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.
    Reisinger EC; Allerberger F
    Wien Klin Wochenschr; 1999 Jul; 111(14):537-8. PubMed ID: 10467639
    [No Abstract]   [Full Text] [Related]  

  • 36. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
    Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
    New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
    Fihman V; Le Monnier A; Corvec S; Jaureguy F; Tankovic J; Jacquier H; Carbonnelle E; Bille E; Illiaquer M; Cattoir V; Zahar JR
    J Infect; 2012 Apr; 64(4):391-8. PubMed ID: 22245400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
    Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
    Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.
    Sánchez A; Gattarello S; Rello J
    Semin Respir Crit Care Med; 2011 Apr; 32(2):151-8. PubMed ID: 21506051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.